Success Story: EB-1A Approval after RFE for a Biotechnology Researcher from India
Client’s Testimonial:
"I liked the professional handling of my case by your organization. All the material provided was gone through in detail, and I was given drafts in a timely manner. Thanks very much for your help, and this indeed is a big relief for my scientific career."
On May 22nd, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Control of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
State of Residence at the Time of Filing: Oklahoma
Approval Notice Date: May 22nd, 2026
Processing Time: 3 months, 18 days (Premium Processing Requested)
Case Summary:
When USCIS issued a Request for Evidence (RFE) only weeks after filing this EB-1A petition, the case quickly became a test of whether highly specialized biotechnology research could be clearly translated into evidence of sustained acclaim and major scientific significance. North America Immigration Law Group (Chen Immigration Law Associates) worked closely with the client, a postdoctoral fellow from India, to build a response that demonstrated both the originality of his work and its growing influence across agricultural biotechnology research.
The client’s research focused on improving plant genome editing, nutrient enhancement, and crop biotechnology through advanced molecular approaches. One independent expert described his work this way:
“His innovative approach testifies to his exceptional capacity to address longstanding limitations in enhancing micronutrient biofortification and bioavailability, thereby highlighting the value of his ongoing research in the field of biotechnology.”
Rather than relying on generalized claims about biotechnology, our legal team structured the petition around objective evidence showing that the client’s research had already achieved broad recognition within the field. His record included 16 peer-reviewed journal articles, 4 conference abstracts, and 3 first-authored book chapters. His publications had accumulated more than 2,300 citations, with multiple papers ranking among the top 10% most-cited Microbiology publications for their respective years. The evidence also showed that his citation performance placed him among the top researchers in his field globally.
The petition further documented that editors and researchers repeatedly relied on his expertise. He had completed 18 peer reviews for respected journals in plant science, biotechnology, and agricultural chemistry, while independent researchers had cited and incorporated his findings into studies involving crop improvement, genome editing technologies, and nutrient-enriched agricultural systems. His research also received support from major U.S. funding agencies, including the National Science Foundation and the National Institute of Food and Agriculture.
After the RFE was issued on February 18, 2026, our legal team prepared a detailed response emphasizing the downstream impact of the client’s work, including independent implementation, scientific reliance, publication influence, and expert testimony confirming the importance of his contributions to biotechnology research. The response successfully demonstrated that the client’s achievements satisfied the EB-1A standard for original contributions of major significance and sustained international recognition.
USCIS approved the I-140 EB-1A petition on May 22, 2026, only 3 months and 18 days after filing. This approval reflects NAILG’s strategic presentation of a case that connected high-impact biotechnology research to the demanding EB-1A evidentiary framework.